Resources Contact Us Home
Antisense oligonucleotides targeted to human CDC45

Image Number 4 for United States Patent #7393950.

Antisense oligonucleotides that inhibit expression of human replication-initiation protein as well as methods of preventing or treating hyperproliferative conditions using said oligonucleotides are disclosed. One aspect provides an antisense oligonucleotides that inhibits the expression of human replication-initiation protein and has a sequence complementary to at least a portion of a target sequence encoding a human replication-initiation gene. By administering a therapeutically effective amount of antisense oligonucleotides or by contacting the hyperproliferating cells with an effective amount of antisense oligonucleotides, expression of replication-initiation protein is inhibited. Methods of screening and testing active antisense oligonucleotides for their ability to inhibit gene expression are also disclosed.

  Recently Added Patents
Potato cultivar F10
Process for preventing polymerization of cracked volatile products during pyrolysis and gasification
Voltage regulators with improved wake-up response
Powder for layerwise manufacturing of objects
Identification wristband
Termite tubing preventative for non-wood materials
Assigning runtime artifacts to software components
  Randomly Featured Patents
Crystalline tantalum containing multinary metal oxide compositions, processes for using the composition
Device for dispensing mascara
Tamper resistant fastening assembly and method of use
Silylated water vapor treated zinc or gallium promoted zeolite and use thereof for the conversion of non-aromatic hydrocarbons to olefins and aromatic hydrocarbons
Process for repairing paint faults in paint layers
Process for producing graphite whiskers
Television link infrared modulation circuit
Air purifier
Fiber optic cable comprising improved filling material and method of fabrication
Treatment of bone disorders